Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry

Diabetes/metabolism Research and Reviews
N DanchinJean-Pierre Cambou

Abstract

The cardiovascular effects of sulfonylureas (SU) in diabetic patients are controversial and it has been suggested that diabetic patients with acute myocardial infarction while on SU were at increased risk. To assess the in-hospital outcome of patients with acute myocardial infarction according to the use of SU at the time of the acute episode. Of 443 intensive care units in France, 369 (83%) prospectively collected all cases of infarction admitted within 48 h of symptom onset in November 2000. Among the 2320 patients included in the registry, 487 (21%) had diabetes, of whom 215 (44%) were on SU. Patients on SU were older and had a more frequent history of hyperlipidemia than those not receiving SU. Type and location of infarction were similar in the two groups, and there was no difference in Killip class on admission. In-hospital mortality was lower in patients on SU (10.2%) than in those without SU (16.9%) (p = 0.035). There was a trend toward less frequent ventricular fibrillation (2.3% vs 5.9%, p = 0.052). In two models of multivariate analyses, SU therapy was associated with decreased in-hospital mortality (model 1: relative risk: 0.44, p = 0.012; model 2: relative risk: 0.37, p = 0.020). In this nationwide registry reflect...Continue Reading

References

Oct 1, 1991·Seminars in Thrombosis and Hemostasis·J Gram, J Jespersen
Jan 1, 1997·The American Journal of Cardiology·S D Correa, S Schaefer
Apr 30, 1998·Journal of the American College of Cardiology·P A Brady, A Terzic
Mar 19, 1999·European Heart Journal·F TomaiP A Gioffrè
Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen

❮ Previous
Next ❯

Citations

Oct 1, 2008·Cardiovascular Drugs and Therapy·Yumei YeYochai Birnbaum
Sep 29, 2005·Current Diabetes Reports·George Dailey
Sep 20, 2011·Diabetes, Obesity & Metabolism·A S AbdelmoneimS H Simpson
Sep 21, 2015·International Journal of Cardiology·Ahmed S AbdelmoneimScot H Simpson
Feb 19, 2014·Diabetes, Obesity & Metabolism·S E Holden, C J Currie
Feb 26, 2015·Diabetes, Obesity & Metabolism·A S AbdelmoneimS H Simpson
Jun 7, 2011·Expert Opinion on Pharmacotherapy·Thomas ForstAndreas Pfützner
Dec 6, 2008·La Presse médicale·Jean-Louis SchliengerBernard Goichot
Aug 13, 2010·The Journal of Clinical Endocrinology and Metabolism·Marianne ZellerUNKNOWN French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction investigators
May 22, 2009·Diabetes/metabolism Research and Reviews·Henriette T HorsdalJørgen Rungby

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.